MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

25 May 2024 Evaluate
The March 2024 quarter revenue stood at Rs. 28940.30 millions, up 20.27% as compared to Rs. 24062.30 millions during the corresponding quarter last year.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 5786.70  millions as against Rs. 5986.80 millions reported during the corresponding quarter ended.Operating profit surged to 8977.60 millions from the corresponding previous quarter of 8561.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 28940.30 24062.30 20.27 106456.40 84570.00 25.88 106456.40 84570.00 25.88
Other Income 1229.70 2801.90 -56.11 6160.60 4439.20 38.78 6160.60 4439.20 38.78
PBIDT 8977.60 8561.10 4.87 28401.00 19488.30 45.73 28401.00 19488.30 45.73
Interest 530.70 317.70 67.04 1826.00 745.80 144.84 1826.00 745.80 144.84
PBDT 8446.90 8243.40 2.47 26575.00 18742.50 41.79 26575.00 18742.50 41.79
Depreciation 648.10 666.80 -2.80 2545.80 2432.60 4.65 2545.80 2432.60 4.65
PBT 7798.80 7576.60 2.93 24029.20 16309.90 47.33 24029.20 16309.90 47.33
TAX 2012.10 1589.80 26.56 5028.20 3888.20 29.32 5028.20 3888.20 29.32
Deferred Tax -64.50 -24.20 166.53 -952.60 -233.40 308.14 -952.60 -233.40 308.14
PAT 5786.70 5986.80 -3.34 19001.00 12421.70 52.97 19001.00 12421.70 52.97
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 31.02 35.58 -12.81 26.68 23.04 15.77 26.68 23.04 15.77
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..